CMS certification 193300
Childrens Hospital
200 Henry Clay Ave, New Orleans, LA 70118
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Clinicians registered at this address
441 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 100 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pediatrics | 73 |
| Pediatric Emergency Medicine | 27 |
| Nurse Anesthetist, Certified Registered | 24 |
| Physician Assistant | 23 |
| Clinical | 17 |
| Anesthesiology | 16 |
| Pediatric Critical Care Medicine | 16 |
| Family | 15 |
| Neonatal-Perinatal Medicine | 12 |
| Pediatric Cardiology | 12 |
| Dietitian, Registered | 10 |
| Neonatal, Critical Care | 9 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $142,999
- 2020 $431,245
- 2021 $235,515
- 2022 $54,838
- 2023 $0
- 2024 $346,905
- 2025 $150,704
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $3,985 | 4 |
| Charitable contributions | $25 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $64,028 | 25 |
| Janssen Research & Development, LLC | $39,463 | 9 |
| Eli Lilly and Company | $26,447 | 4 |
| Syndax Pharmaceuticals, Inc. | $10,625 | 2 |
| National Marrow Donor Program | $4,985 | 5 |
| Pfizer INC. | $4,600 | 2 |
| Novartis Pharmaceuticals Corporation | $275 | 2 |
| Chiesi USA, Inc. | $255 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| MULTICENTER, PROSPECTIVE, OPEN-LABEL, RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE PHARMACOKINETICS (PK), SAFETY, TOLERABILITY OF TAK-881-3001 IN PRIM… Takeda Pharmaceuticals U.S.A., Inc. | $60,050 |
| A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease (DEVELOP) Janssen Research & Development, LLC | $39,463 |
| A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 Eli Lilly and Company · NCT04396574 | $19,753 |
| EXPANDED ACCESS PROGRAM FORSNDX-5613IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIAS WITH GENETIC ALTERATIONS ASSOCIATED WITH HOXA OVEREXPRESSION Syndax Pharmaceuticals, Inc. | $10,625 |
| PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PED… Eli Lilly and Company · NCT04396236 | $6,695 |
| LOW INTERVENTIONAL COHORT STUDY OF MYOCARDITISPERICARDITIS ASSOCIATED WITH COMIRNATY IN PERSONS LESS THAN 21 YEARS OF AGE PFIZER INC. | $4,600 |
| LONG-TERM SAFETY AND TOLERABILITY OF TAK-881 IN SUBJECTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) Takeda Pharmaceuticals U.S.A., Inc. | $3,978 |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research National Marrow Donor Program | $1,000 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Childrens Hospital
Does Childrens Hospital have an emergency room?
Yes. CMS lists emergency services at Childrens Hospital.
Does Childrens Hospital receive money from drug and device companies?
Drug and device makers reported $150,704 in payments to Childrens Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.